🚨 Exciting Opportunity ‼️ The #VHIO Undergraduate International Computational Oncology Award is now OPEN 🚀
Join a one-month stay at VHIO’s computational oncology labs & contribute to cutting-edge cancer research!
Apply now 👉 https://t.co/oLk9IOif75 📅 Deadline: May 23rd
#SOMMVHIO #CRISVHIO
What modifiable risk factors are linked to early-onset colorectal cancer?🧐 Our PostDoc @Silvs_ceM explained today how we use exposome-related methylation scores to answer this question at the Emerging Leaders in Biomedicine co-organized by @vhio.
Last week PhD student @mariabuxi represented our lab at the #ECCB2024 , were she presented a poster with her exciting first results. Had an amazing time at Turku!
(and thanks to @eHealthUOC for sponsoring the trip).
🎙️ ¡No te pierdas el #podcast de #VHIOTalks24 sobre #IA e investigación oncológica!
👩🏻💻 @seoaneja@fran_mj88 y M. José Fariña explican el papel clave de la IA en la lucha contra el cáncer, junto al divulgador @luis_quevedo.
🎧 Escúchalo aquí: https://t.co/JboZt3lCyH
Con @SOMM_alliance
#VHIOTalks
@VHIO@vallhebron Maria Fariña Morillas, from the Cancer Computational Biology Research Group is right now presenting her thesis: "Targeting epigenetic synthetic lethality for cancer treatment". #PhDdayVH
The identification and validation of picloram and lifestyle factors as key risk factors for early-onset colorectal cancer, pave the way for prevention strategies, targeted interventions🎯, and early detection🔎.
Follow us if you want to be updated on this story!
❗️NEW pre-print available
Our latest research on early-onset colorectal cancer (diagnosed in patients <50) identifies picloram (herbicide) as a novel risk factor, while confirming well-known risk factors like smoking habits. #eoCRC#exposome#epigenetics +
https://t.co/nrDIniSQNj
Our approach uses exposome-related methylation scores🧬 to uncover which environmental and lifestyle factors🧘♀️ contribute to early-onset colorectal cancer development compared to cases diagnosed at age 70+. +
This Saturday, our PhD student @mariabuxi joined la #Festadelaciència with the workshop 'De què va això de les mutacions?'👀- @VHIO
Young participants discovered what happens when there is a mistake in the DNA😱 and why is this super important for our research in cancer🔎.
Ciencia vs. Cáncer is the recording of the #VHIOtalks, an initative of @VHIO's PATIENTs program which aims to bring research closer to oncology patients, and put them in the conversation. And our great Phd student @maryjfmy is one of the board members!
Mom, we're in TV! 📺Now streaming the newest episode of Ciencia vs. Cáncer, where @seoaneja and PhD student @maryjfmy, together with @fran_mj88 and @luis_quevedo have an informal conversation on how we use IA in cancer research.
https://t.co/ddAKYb1JFw
Yesterday, our group leader @seoaneja and the amazing @LauraSoucek talked about their adventures in their way to become PIs at @VHIO during May's Pizza talk. Very inspiring stories✨ and super helpful tips for early career researchers👩🔬!
My PhD project revolves around the same topic, as we are trying to elucidate DNA methylation patterns that are associated with dormancy awakening 😴 and late relapses in ER+ breast cancer patients. If you want to know more about the lab's research projects, hang around! - Arnau
We're very very happy to share with you Arnau's first scientific work at @VHIO 🎉. In this brief 'In the Spotlight' for @CD_AACR (https://t.co/ogTYQ18g9L) we featured the recent great work from @MagnaniLab_ICR. 🧵
Their research on ER+ breast cancer showed that certain epigenetic changes associated with dormancy occur during endocrine therapy, and that interfering with these changes reduces the dormant cancer cell population. +